194 related articles for article (PubMed ID: 12682296)
21. Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions.
Cummings JL; Frankel M
Biol Psychiatry; 1985 Oct; 20(10):117-26. PubMed ID: 3862431
[TBL] [Abstract][Full Text] [Related]
22. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
[TBL] [Abstract][Full Text] [Related]
23. Linkage analysis and exclusion of regions of chromosomes 3 and 8 in Gilles de la Tourette syndrome following the identification of a balanced reciprocal translocation 46 XY, t(3:8)(p21.3 q24.1) in a case of Tourette syndrome.
Brett PM; Curtis D; Robertson MM; Dahlitz M; Gurling HM
Psychiatr Genet; 1996; 6(3):99-105. PubMed ID: 8902885
[TBL] [Abstract][Full Text] [Related]
24. Elevated Expression of
Hildonen M; Levy AM; Dahl C; Bjerregaard VA; Birk Møller L; Guldberg P; Debes NM; Tümer Z
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33445578
[TBL] [Abstract][Full Text] [Related]
25. Catechol-O-methyltransferase and Gilles de la Tourette syndrome.
Barr CL; Wigg KG; Sandor P
Mol Psychiatry; 1999 Sep; 4(5):492-5. PubMed ID: 10523824
[TBL] [Abstract][Full Text] [Related]
26. Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome.
Patel C; Cooper-Charles L; McMullan DJ; Walker JM; Davison V; Morton J
Eur J Hum Genet; 2011 Jun; 19(6):634-9. PubMed ID: 21386874
[TBL] [Abstract][Full Text] [Related]
27. Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences?
Cath DC; Spinhoven P; Hoogduin CA; Landman AD; van Woerkom TC; van de Wetering BJ; Roos RA; Rooijmans HG
Psychiatry Res; 2001 Mar; 101(2):171-85. PubMed ID: 11286820
[TBL] [Abstract][Full Text] [Related]
28. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome.
Leckman JF; Pauls DL; Zhang H; Rosario-Campos MC; Katsovich L; Kidd KK; Pakstis AJ; Alsobrook JP; Robertson MM; McMahon WM; Walkup JT; van de Wetering BJ; King RA; Cohen DJ;
Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):60-8. PubMed ID: 12497616
[TBL] [Abstract][Full Text] [Related]
29. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
Cath DC; Spinhoven P; Landman AD; van Kempen GM
J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
[TBL] [Abstract][Full Text] [Related]
30. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
[TBL] [Abstract][Full Text] [Related]
31. Obsessive compulsive symptoms in Gilles de la Tourette syndrome and obsessive compulsive disorder: differences by diagnosis and family history.
Eapen V; Robertson MM; Alsobrook JP; Pauls DL
Am J Med Genet; 1997 Jul; 74(4):432-8. PubMed ID: 9259380
[TBL] [Abstract][Full Text] [Related]
32. The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome.
Pauls DL
Psychiatr Clin North Am; 1992 Dec; 15(4):759-66. PubMed ID: 1461793
[TBL] [Abstract][Full Text] [Related]
33. 9p monosomy in a patient with Gilles de la Tourette's syndrome.
Taylor LD; Krizman DB; Jankovic J; Hayani A; Steuber PC; Greenberg F; Fenwick RG; Caskey CT
Neurology; 1991 Sep; 41(9):1513-5. PubMed ID: 1679912
[TBL] [Abstract][Full Text] [Related]
34. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
Szejko N; Saramak K; Lombroso A; Müller-Vahl K
Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
[TBL] [Abstract][Full Text] [Related]
35. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
Kompoliti K; Goetz CG
Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
[TBL] [Abstract][Full Text] [Related]
36. The Gilles de la Tourette syndrome and obsessional disorder.
Robertson MM
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():69-82; discussion 82-4. PubMed ID: 1806636
[TBL] [Abstract][Full Text] [Related]
37. Association study between Gilles de la Tourette Syndrome and two genes in the Robo-Slit pathway located in the chromosome 11q24 linked/associated region.
Miranda DM; Wigg K; Feng Y; Sandor P; Barr CL
Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):68-72. PubMed ID: 17671968
[TBL] [Abstract][Full Text] [Related]
38. Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.
Bertelsen B; Melchior L; Jensen LR; Groth C; Glenthøj B; Rizzo R; Debes NM; Skov L; Brøndum-Nielsen K; Paschou P; Silahtaroglu A; Tümer Z
Eur J Hum Genet; 2014 Nov; 22(11):1283-9. PubMed ID: 24549057
[TBL] [Abstract][Full Text] [Related]
39. Deep brain stimulation for Gilles de la Tourette syndrome in children and youth: a meta-analysis with individual participant data.
Coulombe MA; Elkaim LM; Alotaibi NM; Gorman DA; Weil AG; Fallah A; Kalia SK; Lipsman N; Lozano AM; Ibrahim GM
J Neurosurg Pediatr; 2018 Oct; 23(2):236-246. PubMed ID: 30497215
[TBL] [Abstract][Full Text] [Related]
40. A family study of Gilles de la Tourette syndrome.
Pauls DL; Raymond CL; Stevenson JM; Leckman JF
Am J Hum Genet; 1991 Jan; 48(1):154-63. PubMed ID: 1985456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
